Resources with keywords: candida auris
C. auris is the first fungal pathogen designated an urgent antimicrobial resistance threat. 6,304 U.S. clinical cases in 2024; estimated ~7,000 in 2025. C. auris persists on surfaces and medical equipment for weeks; HCWs involved in wound care, catheter insertion, and line management are at highest risk of pathogen carriage and inadvertent transmission. Clinical mycology laboratory personnel should use BSL-2 precautions. Environmental sampling of patient rooms is recommended. Echinocandin-resistant strains increasing; consult infectious disease specialist for treatment.
Kurutz A, Innes GK, Sherman A, et al.
Candida auris, a frequently multidrug-resistant fungal pathogen, can spread within health care facilities. Dialysis facilities face particular infection prevention and control (IPC) challenges because their patients require complex medical care and frequent invasive procedures.
Cristina ML, Spagnolo AM, Sartini M, Carbone A, Oliva M, Schinca E, Boni S, Pontali E
This pathogenic fungus shows an innate resilience, enabling survival and persistence in healthcare environment and the ability to rapidly colonize the patient’s skin and be easily transmitted within the healthcare setting, thus leading to a serious and prolonged outbreak.
